NOX1 supports the metabolic remodeling of HepG2 cells

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Bertram, Katharina ^a   Valcu, Cristina Maria ^a,c   Weitnauer, Michael ^a,d   Linne, Uwe ^b   Görlach, Agnes ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c MAX PLANCK INSTITUTE FOR ORNITHOLOGY   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUTAMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; NOX1 PROTEIN, HUMAN; PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL INTERFERING RNA;

AMINO ACID METABOLISM; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE METABOLISM; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LIPID METABOLISM; LIVER CANCER; METABOLIC REGULATION; METABOLIC REMODELING; METABOLISM; NUCLEOTIDE METABOLISM; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; ANTAGONISTS AND INHIBITORS; DOWN REGULATION; GENETICS; HEP-G2 CELL LINE; RNA INTERFERENCE; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLUCOSE; GLUTAMINE; HEP G2 CELLS; HUMANS; LIPID METABOLISM; METABOLIC NETWORKS AND PATHWAYS; NADPH OXIDASE; PROTEINS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TANDEM MASS SPECTROMETRY; UP-REGULATION;

EID: 84925989773     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122002     Document Type: Article

References (107)

1. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev. 2007; 87: 245-313. PMID: 17237347
2. Lambeth JD. Nox enzymes and the biology of reactive oxygen. Nat Rev Immunol. 2004; 4: 181-189. PMID: 15039755
3. Kamata T. Roles of Nox1 and other Nox isoforms in cancer development. Cancer Sci. 2009; 100: 1382-1388. doi: 10.1111/j.1349-7006.2009.01207.x PMID: 19493276
4. Block K, Gorin Y. Aiding and abetting roles of NOX oxidases in cellular transformation. Nat Rev Cancer 2012; 12: 627-637. doi: 10.1038/nrc3339 PMID: 22918415
5. Mitsushita J, Lambeth JD, Kamata T. The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation. Cancer Res. 2004; 64: 3580-3585. PMID: 15150115
6. Laurent E, McCoy JW III, Macina RA, Liu W, Cheng G, Robine S, et al. Nox1 is over-expressed in human colon cancers and correlates with activating mutations in K-Ras. Int J Cancer. 2008; 123: 100-107. doi: 10.1002/ijc.23423 PMID: 18398843
7. Cheng G, Diebold BA, Hughes Y, Lambeth JD. Nox1-dependent reactive oxygen generation is regulated by Rac1. J Biol Chem. 2006; 281: 17718-17726. PMID: 16636067
8. Petry A, Weitnauer M, Goerlach A. Receptor activation of NADPH oxidases. Antioxid Redox Sign. 2010; 13: 467-487. doi: 10.1089/ars.2009.3026 PMID: 20001746
9. Fukuyama M, Rokutan K, Sano T, Miyake H, Shimada M, Tashiro S. Overexpression of a novel superoxide-producing enzyme, NADPH oxidase 1, in adenoma and well differentiated adenocarcinoma of the human colon. Cancer Lett. 2005; 221: 97-104. PMID: 15797632
10. Tominaga K, Kawahara T, Sano T, Toida K, Kuwano Y, Sasaki H et al. Evidence for cancer-associated expression of NADPH oxidase 1 (Nox1)-based oxidase system in the human stomach. Free Radical Bio Med. 2007; 43: 1627-1638.
11. Lim SD, Sun C, Lambeth JD, Marshall F, Amin M, Chung L, et al. Increased noxl and hydrogen peroxide in prostate cancer. Prostate. 2005; 62: 200-207. PMID: 15389790
12. Shimada K, Nakamura M, Anai S, De Velasco M, Tanaka M, Tsujikawa K, et al. A novel human AlkB homologue, ALKBH8, contributes to human bladder cancer progression. Cancer Res. 2009; 69: 3157-3164. doi: 10.1158/0008-5472.CAN-08-3530 PMID: 19293182
13. Block K, Gorin Y, New DD, Eid A, Chelmicki T, Reed A, et al. The NADPH oxidase subunit p22(phox) inhibits the function of the tumor suppressor protein tuberin. Am J Pathol. 2010; 176: 2447-2455. doi: 10.2353/ajpath.2010.090606 PMID: 20304964
14. Desouki MM, Kulawiec M, Bansal S, Das G, Singh KK. Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors. Cancer Biol Ther. 2005; 4: 1367-1373. PMID: 16294028
15. Geiszt M, Lekstrom K, Brenner S, Hewitt SM, Dana R, Malech HL, et al. NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91(phox) in the regulated production of superoxide by phagocytes. J Immunol. 2003; 171: 299-306. PMID: 12817011
16. Shinohara M, Shang W-H, Kubodera M, Harada S, Mitsushita J, Kato M, et al. Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho. J Biol Chem. 2007, 282: 17640-17648. PMID: 17435218
17. Adachi Y, Shibai Y, Mitsushita J, Shang WH, Hirose K, Kamata T. Oncogenic Ras upregulates NADPH oxidase 1 gene expression through MEK-ERK-dependent phosphorylation of GATA-6. Oncogene. 2008; 27: 4921-4932. doi: 10.1038/onc.2008.133 PMID: 18454176
18. Puca R, Nardinocchi L, Starace G, Rechavi G, Sacchi A, Givol D, et al. Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis. Free Radical Bio Med. 2010, 48: 1338-1346. doi: 10.1016/j.freeradbiomed.2010.02.015 PMID: 20171273
19. Sancho P, Fabregat I. NADPH Oxidase NOX1 Controls Autocrine Growth of Liver Tumor Cells through Up-regulation of the Epidermal Growth Factor Receptor Pathway. J Biol Chem. 2010; 285: 24815-24824. doi: 10.1074/jbc.M110.114280 PMID: 20525691
20. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res. 1982; 42: 3858-3863. PMID: 6286115
21. Petry A, Djordjevic T, Weitnauer M, Kietzmann T, Hess J, Goerlach A. NOX2 and NOX4 mediate proliferative response in endothelial cells. Antioxid Redox Sign. 2006; 8: 1473-1484. PMID: 16987004
22. R-Development-Core-Team. R: A language and environment for statistical computing, R Foundation for Statistical Computing. Vienna, Austria. 2006; http://www.R-project.org. PMID: 18000755
23. Lapsley M, Ripley B. ODBC Database Connectivity 2011; R package version 13-3.
24. Pinheiro J, Bates D, DebRoy S, Sarkar D. nlme: Linear and nonlinear mixed effects models. 2006; R package version 31-102.
25. Fox J. effects: Effect Displays for Linear and Generalized Linear Models. 2006; R package version 21-0.
26. Sarkar D. Lattice: Multivariate Data Visualization with R. 2008; R package version 020-0.
27. Harrell FE. Hmisc S function library. 2004; R package version 39-0.
28. Hothorn T. Multcomp. 2011; R package version
29. Warnes GR. ssize: Compute and plot power, reqired sample-size, or detectible effect size for gene expression experiment. 2009; R package version 1280.
30. Valcu C-M, Junqueira M, Shevchenko A, Schlink K. Comparative proteomic analysis of responses to pathogen infection and wounding in Fagus sylvatica. J Proteome Res. 2009; 8: 4077-4091. doi: 10.1021/pr900456c PMID: 19575529
31. Anderson NL, Esquerblasco R, Hofmann JP, Anderson NG. A 2-dimensional gel database of rat liver proteins useful in gene regulation and drug effects studies. Electrophoresis. 1991; 12: 907-930. PMID: 1724422
32. Djordjevic T, Pogrebniak A, BelAiba RS, Bonello S, Wotzlaw C, Acker H, et al. The expression of the NADPH oxidase subunit p22phox is regulated by a redox-sensitive pathway in endothelial cells. Free Radical Bio Med. 2005; 38: 616-630. PMID: 15683718
33. Pinheiro JC, Bates DM. Mixed-effects models in S and S-PLUS. 2000; Springer.
34. Rampersad SN. Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays. Sensors. 2012; 12: 12347-12360. doi: 10.3390/s120912347 PMID: 23112716
35. Shevchenko A, Valcu C-M, Junqueira M. Tools for exploring the proteomosphere. J Proteomics. 2009; 72: 137-144. doi: 10.1016/j.jprot.2009.01.012 PMID: 19167528
36. Jin JY, Cai Y, Yao T, Gottschalk AJ, Florens L, Swanson SK, et al. A mammalian chromatin remodeling complex with similarities to the yeast INO80 complex. J Biol Chem. 2005; 280: 41207-41212. PMID: 16230350
37. Warburg O, Wind F, Negelein E. The metabolism of tumours in the body. J Gen Physiol. 1927; 8: 519-530. PMID: 19872213
38. Alberghina L, Gaglio D, Gelfi C, Moresco RM, Mauri G, Bertolazzi P, et al. Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling. Front Physiol. 2012; 3: Article 362.
39. Codarin E, Renzone G, Poz A, Avellini C, Baccarani U, Lupo F, et al. Differential proteomic analysis of subfractioned human hepatocellular carcinoma tissues. J Proteome Res. 2009; 8: 2273-2284. doi: 10.1021/pr8009275 PMID: 19290626
40. Lea MA, Morris HP, Murphy P. Glycogen metabolism in regenerating liver and liver neoplasms. Cancer Res. 1972; 32: 61-&. PMID: 4332474
41. Chopra A, Iyer VK, Agarwala S, Mathur SR, Aron M, Gupta SD, et al. Apoptotic protein expression, glycogen content, DNA ploidy and cell proliferation in hepatoblastoma subtyping and their role in prognostication. Pediatr Surg Int. 2010; 26: 1173-1178. doi: 10.1007/s00383-010-2699-x PMID: 20803149
42. Li L, He Q, Huang X, Man Y, Zhou Y, Wang S, et al. NOX3-derived reactive oxygen species promote TNF-alpha-induced reductions in hepatocyte glycogen levels via a JNK pathway. Febs Lett. 2010; 584: 995-1000. doi: 10.1016/j.febslet.2010.01.044 PMID: 20102709
43. Lu W, Hu Y, Chen G, Chen Z, Zhang H, Wang F, et al. Novel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapy. PLoS Biol. 2012; 10: e1001326. doi: 10.1371/journal.pbio.1001326 PMID: 22589701
44. Li C, Hong Y, Tan YX, Zhou H, Ai JH, Li SJ, et al. Accurate qualitative and quantitative proteomic analysis of clinical hepatocellular carcinoma using laser capture microdissection coupled with isotope-coded affinity tag and two-dimensional liquid chromatography mass spectrometry. Mol Cell Proteomics. 2004; 3: 399-409. PMID: 14726492
45. Méndez-Lucas A, Hyroššová P, Novellasdemunt L, Viñals F, Perales JC. Mitochondrial PEPCK is a Pro-Survival, ER-Stress Response Gene Involved in Tumor Cell Adaptation to Nutrient Availability. J Biol Chem. 2014; jbc. M114. 566927.
46. Leithner K, Hrzenjak A, Trötzmüller M, Moustafa T, Köfeler H, Wohlkoenig C, et al. PCK2 activation mediates an adaptive response to glucose depletion in lung cancer. Oncogene. 2015; 34: 1044-1050. doi: 10.1038/onc.2014.47 PMID: 24632615
47. Matsuno T. Pathway of glutamate oxidation and its regulation in the huh13 line of human hepatoma cells. J Cell Physiol. 1991; 148: 290-294. PMID: 1679060
48. Glazer RI, Vogel CL, Patel IR, Anthony PP. Glutamate dehydrogenase activity related to histopathological grade of hepatocellular carcinoma inman. Cancer Res. 1974; 34: 2975-2978. PMID: 4370643
49. Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 2013; 496: 101-105. doi: 10.1038/nature12040 PMID: 23535601
50. Zhang F, Du G. Dysregulated lipid metabolism in cancer. World J Biol Chem. 2012; 3: 167. doi: 10.4331/wjbc.v3.i8.167 PMID: 22937213
51. Li YC, Park MJ, Ye SK, Kim CW, Kim YN. Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. Am J Pathol. 2006; 168: 1107-1118. PMID: 16565487
52. Kawata S, Takaishi K, Nagase T, Ito N, Matsuda Y, Tamura S, et al. Increase in the active form of 3-hydroxy-3-methylglutaryl coenzime A reductase in human hepatocellular carcinoma - possible mechanism for alteration of cholesterol biosynthesis. Cancer Res. 1990; 50: 3270-3273. PMID: 2159376
53. Bricker LA, Siperste Md, Morris HP. Loss of cholesterol feedback system in intact hepatoma bearing rat. J Clin Invest. 1972; 51: 206-&. PMID: 4333018
54. Li LO, Klett EL, Coleman RA. Acyl-CoA synthesis, lipid metabolism and lipotoxicity. BBA-Mol Cell Biol L. 2010; 1801: 246-251. doi: 10.1016/j.bbalip.2009.09.024 PMID: 19818872
55. Li LO, Ellis JM, Paich HA, Wang S, Gong N, Altshuller G, et al. Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and β-oxidation and alters phospholipid fatty acid composition. J Biol Chem. 2009; 284: 27816-27826. doi: 10.1074/jbc.M109.022467 PMID: 19648649
56. Parkes HA, Preston E, Wilks D, Ballesteros M, Carpenter L, Wood L, et al. Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo. Am J Physiol-Endoc M. 2006; 291: E737-E744. PMID: 16705061
57. Chaerkady R, Harsha HC, Nalli A, Gucek M, Vivekanandan P, Akhtar J, et al. A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma. J Proteome Res. 2008; 7: 4289-4298. doi: 10.1021/pr800197z PMID: 18715028
58. White-Gilbertson S, Kurtz DT, Voelkel-Johnson C. The role of protein synthesis in cell cycling and cancer. Mol Oncol. 2009; 3: 402-408. doi: 10.1016/j.molonc.2009.05.003 PMID: 19546037
59. White-Gilbertson S, Kurtz DT, Voelkel-Johnson C. The role of protein synthesis in cell cycling and cancer. Mol Oncol. 2009; 3: 402-408. doi: 10.1016/j.molonc.2009.05.003 PMID: 19546037
60. Peng Y, Li Y, Gellert LL, Zou X, Wang J, Singh B, et al. Androgen receptor coactivator p44/Mep50 in breast cancer growth and invasion. J Cell Mol Med. 2010; 14: 2780-2789. doi: 10.1111/j.1582-4934.2009.00936.x PMID: 19840198
61. Friesen WJ, Wyce A, Paushkin S, Abel L, Rappsilber J, Mann M, et al. A novel WD repeat protein component of the methylosome binds Sm proteins. J Biol Chem. 2002; 277: 8243-8247. PMID: 11756452
62. Peng Y, Chen F, Melamed J, Chiriboga L, Wei J, Kong X, et al. Distinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgen-independent prostate cancer. P Natl Acad Sci USA. 2008; 105: 5236-5241. doi: 10.1073/pnas.0712262105 PMID: 18356297
63. Kim JY, Lee K-S, Seol JE, Yu K, Chakravarti D, Seo SB. Inhibition of p53 acetylation by INHAT subunit SET/TAF-I beta represses p53 activity. Nucleic Acids Res. 2012; 40: 75-87. doi: 10.1093/nar/gkr614 PMID: 21911363
64. Ouellet V, Le Page C, Guyot M-C, Lussier C, Tonin PN, Provencher DM, et al. SET complex in serous epithelial ovarian cancer. Int J Cancer. 2006; 119: 2119-2126. PMID: 16823850
65. Li C, Ruan H-Q, Liu Y-S, Xu M-J, Dai J, Sheng QH, et al. Quantitative proteomics reveal up-regulated protein expression of the SET complex associated with hepatocellular carcinoma. J Proteome Res. 2011; 11: 871-885. doi: 10.1021/pr2006999 PMID: 22082227
66. Lee JS, Chu IS, Heo J, Calvisi DF, Sun ZT, Roskams T, et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology. 2004; 40: 667-676. PMID: 15349906
67. Rechsteiner M, Realini C, Ustrell V. The proteasome activator 11 S REG (PA28) and Class I antigen presentation. Biochem J. 2000; 345: 1-15. PMID: 10600633
68. Seifert U, Bialy LP, Ebstein F, Bech-Otschir D, Voigt A, Schroeter F, et al. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell. 2010; 142: 613-624. doi: 10.1016/j.cell.2010.07.036 PMID: 20723761
69. Frohlich M, Motte P, Galvin K, Takahashi H, Wands J, Ozturk M. Enhanced expression of the protein kinase substrate p36 in human hepatocallular carcinoma. Mol Cell Biol. 1990; 10: 3216-3223. PMID: 2160596
70. Liang R, Neo JCH, Lo SL, Tan GS, Seow TK, Chung MCM. Proteome database of hepatocellular carcinoma. J Chromatogr B. 2002; 771: 303-328. PMID: 12016006
71. Fella K, Gluckmann M, Hellmann J, Karas M, Kramer PJ, Kroger M. Use of two-dimensional gel electrophoresis in predictive toxicology: Identification of potential early protein biomarkers in chemically induced hepatocarcinogenesis. Proteomics. 2005; 5: 1914-1927. PMID: 15816005
72. Wang CY, Lin CF. Annexin A2: its molecular regulation and cellular expression in cancer development. Dis Markers. 2014; Article ID 308976.
73. Mayer G, Poirier S, Seidah NG. Annexin A2 Is a C-terminal PCSK9-binding Protein That Regulates Endogenous Low Density Lipoprotein Receptor Levels. J Biol Chem. 2008; 283: 31791-31801. doi: 10.1074/jbc.M805971200 PMID: 18799458
74. Chintagari NR, Jin N, Wang PC, Narasaraju TA, Chen JW, Liu L. Effect of cholesterol depletion on exocytosis of alveolar type II cells. Am J Resp Cell Mol. 2006; 34: 677-687.
75. Mohammad HS, Kurokohchi K, Yoneyama H, Tokuda M, Morishita A, Jian G, et al. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Int Journal Oncol. 2008; 33: 1157-1163. PMID: 19020748
76. Tanaka T, Akatsuka S, Ozeki M, Shirase T, Hiai H, Toyokuni S. Redox regulation of annexin 2 and its implications for oxidative stress-induced renal carcinogenesis and metastasis. Oncogene. 2004; 23: 3980-3989. PMID: 15048081
77. Huang Y, Jin Y, Yan C-H, Yu Y, Bai J, Chen F, et al. Involvement of Annexin A2 in p53 induced apoptosis in lung cancer. Mol Cell Biochem. 2008; 309: 117-123. PMID: 18008140
78. Niimi S, Harashima M, Gamou M, Hyuga M, Seki T, Ariga T, et al. Expression of annexin A3 in primary cultured parenchymal rat hepatocytes and inhibition of DNA synthesis by suppression of annexin A3 expression using RNA interference. Biol Pharm Bull. 2005; 28: 424-428. PMID: 15744063
79. Harashima M, Harada K, Ito Y, Hyuga M, Seki T, Ariga T, et al. Annexin A3 expression increases in hepatocytes and is regulated by hepatocyte growth factor in rat liver regeneration. J Biochem. 2008; 143: 537-545. doi: 10.1093/jb/mvm248 PMID: 18182385
80. Liu YF, Xiao ZQ, Li MX, Li MY, Zhang PF, Li C, et al. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma. J Pathol. 2009; 217: 54-64. doi: 10.1002/path.2429 PMID: 18798225
81. Park JE, Lee DH, Lee JA, Park SG, Kim NS, Park BC, et al. Annexin A3 is a potential angiogenic mediator. Biochem Bioph Res Co. 2005; 337: 1283-1287.
82. Görlach A, Diebold I, Schini-Kerth VB, Berchner-Pfannschmidt U, Roth U, Brandes RP, et al. Thrombin activates the Hypoxia-Inducible Factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22phox-containing NADPH oxidase. Circ Res. 2001; 89: 47-54. PMID: 11440977
83. Igleslas J, Abernethy VE, Wang ZY, Lieberthal W, Koh JS, Levine JS. Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROS. Am J Physiol-Renal. 1999; 277: F711-F722. PMID: 10564234
84. Jones DT, Ganeshaguru K, Anderson RJ, Jackson TR, Bruckdorfer KR, Low SY, et al. Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. Blood. 2003; 101: 3174-3180. PMID: 12480711
85. Villa P, Arioli P, Guaitani A. Protein turnover, synthesis and secretion of albumin in hepatocytes isolated from rats bearing Walker 256 carcinoma. In Vitro Cell Dev-An. 1992; 28A: 157-160. PMID: 1582989
86. Desdouets C, Fabre M, Gauthier F, Brechot C, Sobczakthepot J. Proliferation and differentiation of a human hepatoblastoma transplanted in the nudemouse. J Hepatol. 1995; 23: 569-577. PMID: 8583146
87. Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature. Nutr J. 2010; 9: 69. doi: 10.1186/1475-2891-9-69 PMID: 21176210
88. Rasheed Z, Ahmad R, Rasheed N, Ali R. Reactive oxygen species damaged human serum albumin in patients with hepatocellular carcinoma. J Exp Clin Canc Res. 2007; 26: 395-404.
89. Murray MJ, Nicholson JC. alpha-Fetoprotein. Arch Dis Childhood-E. 2011; 96: 141-147.
90. Abelev GI, Eraiser TL. Cellular aspects of alpha-fetoprotein reexpression in tumors. Semin Cancer Biol. 1999; 9: 95-107. PMID: 10202131
91. Kuhlmann WD, Peschke P. Hepatic progenitor cells, stem cells, and AFP expression in models of liver injury. Int J Exp Pathol. 2006; 87: 343-359. PMID: 16965562
92. Yokoo H, Kondo T, Fujii K, Yamada T, Todo S, Hirohashi S. Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells. Hepatology. 2004; 40: 609-617. PMID: 15349899
93. Geiszt M, Lekstrom K, Brenner S, Hewitt SM, Dana R, Malech HL, et al. NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91phox in the regulated production of superoxide by phagocytes. J Immunol. 2003; 171: 299-306. PMID: 12817011
94. Sell S, Thomas K, Michalson M, Salatrepat J, Bonner J. Control of albumin and alpha-fetoprotein expression in rat liver and in some transplantable hepatocellular carcinomas. BBA. 1979; 564: 173-178. PMID: 93970
95. Niwa Y, Matsumura M, Shiratori Y, Imamura M, Kato N, Shina S, et al. Quantitation of alpha-fetoprotein and albumin messenger RNAs in human hepatocellular carcinoma. Hepatology. 1996; 23: 1384-1392. PMID: 8675155
96. Adams JC. Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol. 2004; 16: 590-596. PMID: 15363811
97. Mosialos G, Yamashiro S, Baughman RW, Matsudaira P, Vara L, Matsumura F, et al. Epstein-Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55 kilodalton actin bundling protein. J Virol. 1994; 68: 7320-7328. PMID: 7933116
98. Hashimoto Y, Skacel M, Adams JC. Roles of fascin in human carcinoma motility and signaling: Prospects for a novel biomarker? Int J Biochem Cell B. 2005; 37: 1787-1804. PMID: 16002322
99. Iguchi T, Aishima S, Umeda K, Sanefuji K, Fujita N, Sugimachi K, et al. Fascin expression in progression and prognosis of hepatocellular carcinoma. J Surg Onc. 2009; 100: 575-579.
100. Hayashi Y, Osanai M, Lee GH. Fascin-1 expression correlates with repression of E-cadherin expression in hepatocellular carcinoma cells and augments their invasiveness in combination with matrix metalloproteinases. Cancer Sci. 2011; 102: 1228-1235. doi: 10.1111/j.1349-7006.2011.01910.x PMID: 21323792
101. Sadok A, Bourgarel-Rey V, Gattacceca F, Penel C, Lehmann M, Kovacic H. Nox1-dependent superoxide production controls colon adenocarcinoma cell migration. BBA-Mol Cell Res. 2008; 1783: 23-33. PMID: 18023288
102. Sadok A, Pierres A, Dahan L, Prevot C, Lehmann M, Kovacic H. NADPH oxidase 1 controls the persistence of directed cell migration by a Rho-dependent switch of alpha 2/alpha 3 integrins. Mol Cell Biol. 2009; 29: 3915-3928. doi: 10.1128/MCB.01199-08 PMID: 19451223
103. Kawano K, Kantak SS, Murai M, Yao CC, Kramer RH. Integrin alpha 3 beta 1 engagement disrupts intercellular adhesion. Exp Cell Res. 2001; 262: 180-196. PMID: 11139342
104. Pellegrini S, Censini S, Guidotti S, Iacopetti P, Rocchi M, Bianchi M, et al. A human short-chain dehydrogenase/reductase gene: structure, chromosomal localization, tissue expression and subcellular localization of its product. BBA-Gene Struct Expr. 2002; 1574: 215-222. PMID: 11997086
105. Shafqat N, Shafqat J, Eissner G, Marschall HU, Tryggvason K, Eriksson U, et al. Hep27, a member of the short-chain dehydrogenase/reductase family, is an NADPH-dependent dicarbonyl reductase expressed in vascular endothelial tissue. Cell Mol Life Sci. 2006; 63: 1205-1213. PMID: 16685466
106. Monge M, Colas E, Doll A, Gil-Moreno A, Castellvi J, Diaz B, et al. Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress. Carcinogenesis. 2009; 30: 1288-1297. doi: 10.1093/carcin/bgp119 PMID: 19443906
107. Deisenroth C, Thorner AR, Enomoto T, Perou CM, Zhang Y. Mitochondrial HEP27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53. Mol Cell Biol. 2010; 30: 3981-3993. doi: 10.1128/MCB.01284-09 PMID: 20547751